Anika Therapeutics launches RevoMotion: advancements in reverse shoulder arthroplasty

Pubblicato da Meba il


Anika Therapeutics has recently launched its RevoMotion Reverse Shoulder Arthroplasty System, entering a market estimated at $1 billion.

Cheryl Blanchard, Ph.D., President and CEO of Anika, shared insights on the RevoMotion launch, the role of Ambulatory Surgery Centers (ASCs) in the shoulder market, and expectations for robotics in shoulder surgery. The discussion has been summarized below for clarity.

RevoMotion’s Progress: Since the limited release of RevoMotion discussed at AAOS, the system has seen significant development. Over a hundred cases have been successfully completed, garnering 100% positive feedback from clinicians on implants, design, and surgical techniques. Patients’ positive recovery experiences have resulted in increased demand for the procedure on their other shoulder.

Distinctive Features of RevoMotion: In a competitive reverse shoulder arthroplasty market, RevoMotion stands out due to Anika’s bone-sparing, motion-preserving Arthrosurface design philosophy. Notably, the system features the smallest threaded glenoid baseplate in the market, offering surgeons enhanced flexibility in placement. The mid-lay humeral design and the efficiency of a two-tray instrument set further contribute to its uniqueness.

ASCs in the Total Shoulder Replacement Market: The role of Ambulatory Surgery Centers (ASCs) is gaining significance, especially with CMS planning to reimburse Total Shoulder Arthroplasty procedures in ASCs from 2024. This shift is expected to provide greater flexibility for patients and cost savings for the healthcare system. The preference for ASCs over hospitals among orthopedic patients aligns with the perception of needing a fix rather than being sick, resulting in lower costs for all involved.

Impact of Robotics on Shoulder Replacement: While acknowledging the importance of preoperative planning, Anika has not ventured into the robotics space. Initial releases from other companies appear to be taking longer and lacking substantial benefits. Adoption of robotics in shoulder surgery may be gradual, with a need to demonstrate clear clinical benefits such as improved implant placement, faster surgery, or reduced blood loss. The presentation of such data is likely to drive broader acceptance in the future.